Literature DB >> 16529092

Diagnosis and management of diastolic dysfunction and heart failure.

Chhabi Satpathy1, Trinath K Mishra, Ruby Satpathy, Hemant K Satpathy, Eugene Barone.   

Abstract

Diastolic heart failure occurs when signs and symptoms of heart failure are present but left ventricular systolic function is preserved (i.e., ejection fraction greater than 45 percent). The incidence of diastolic heart failure increases with age; therefore, 50 percent of older patients with heart failure may have isolated diastolic dysfunction. With early diagnosis and proper management the prognosis of diastolic dysfunction is more favorable than that of systolic dysfunction. Distinguishing diastolic from systolic heart failure is essential because the optimal therapy for one may aggravate the other. Although diastolic heart failure is clinically and radiographically indistinguishable from systolic heart failure, normal ejection fraction and abnormal diastolic function in the presence of symptoms and signs of heart failure confirm diastolic heart failure. The pharmacologic therapies of choice for diastolic heart failure are angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, diuretics, and beta blockers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529092

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  24 in total

1.  Heart failure with a normal ejection fraction: treatments for a complex syndrome?

Authors:  Samuel Bernard; Mathew S Maurer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

Review 2.  Diastolic dysfunction: a link between hypertension and heart failure.

Authors:  Sophie Lalande; Bruce D Johnson
Journal:  Drugs Today (Barc)       Date:  2008-07       Impact factor: 2.245

3.  The role of nodose ganglia in the regulation of cardiovascular function following pulmonary exposure to ultrafine titanium dioxide.

Authors:  Hong Kan; Zhongxin Wu; Yen-Chang Lin; Teh-Hsun Chen; Jared L Cumpston; Michael L Kashon; Steve Leonard; Albert E Munson; Vincent Castranova
Journal:  Nanotoxicology       Date:  2013-05-07       Impact factor: 5.913

4.  Galectin-3 as a new biomarker of diastolic dysfunction in hemodialysis patients.

Authors:  Ozgul Malcok Gurel; Hakki Yilmaz; Tugrul H Celik; Muzaffer Cakmak; Mehmet Namuslu; Ayse M Bilgiç; Nuket Bavbek; Ali Akcay; Beyhan Eryonucu
Journal:  Herz       Date:  2015-05-20       Impact factor: 1.443

Review 5.  Striated muscle function, regeneration, and repair.

Authors:  I Y Shadrin; A Khodabukus; N Bursac
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

Review 6.  One problem two issues! Left ventricular systolic and diastolic dysfunction in aortic stenosis.

Authors:  Maqsood M Elahi; Anthony Chuang; Michael J Ewing; Charles H Choi; Peter W Grant; Bashir M Matata
Journal:  Ann Transl Med       Date:  2014-01

7.  Determinants of excessive daytime sleepiness and fatigue in adults with heart failure.

Authors:  Barbara Riegel; Sarah J Ratcliffe; Steven L Sayers; Sheryl Potashnik; Harleah G Buck; Claudine Jurkovitz; Sarah Fontana; Terri E Weaver; William S Weintraub; Lee R Goldberg
Journal:  Clin Nurs Res       Date:  2011-08-30       Impact factor: 2.075

8.  [Heart failure with preserved left ventricular ejection fraction].

Authors:  Johannes Petutschnigg; Frank Edelmann
Journal:  Internist (Berl)       Date:  2019-09       Impact factor: 0.743

9.  Effects of levodopa therapy on global left ventricular systolic function in patients with Parkinson disease.

Authors:  Zeki Yüksel Günaydın; Osman Bektaş; Ahmet Karagöz; Fahriye Feriha Özer
Journal:  Wien Klin Wochenschr       Date:  2016-06-24       Impact factor: 1.704

10.  The evolutionarily conserved C-terminal peptide of troponin I is an independently configured regulatory structure to function as a myofilament Ca2+-desensitizer.

Authors:  Sienna Wong; Han-Zhong Feng; J-P Jin
Journal:  J Mol Cell Cardiol       Date:  2019-09-07       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.